التفاصيل البيبلوغرافية
| العنوان: |
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes. |
| المؤلفون: |
Peters, Marion G, Yuen, Man-Fung, Terrault, Norah, Fry, John, Lampertico, Pietro, Gane, Ed, Hwang, Carey, Stamm, Luisa M, Leus, Mitchell, Maini, Mala K, Mendez, Patricia, Lonjon-Domanec, Isabelle, Berg, Thomas, Wang, Su, Mishra, Poonam, Donaldson, Eric, Buchholz, Stephanie, Miller, Veronica, Lenz, Oliver |
| المصدر: |
Clinical Infectious Diseases; 4/15/2024, Vol. 78 Issue 4, p983-990, 8p |
| مصطلحات موضوعية: |
COMBINATION drug therapy, PATIENT selection, CHRONIC hepatitis B, DNA, TREATMENT effectiveness, ANTIGENS, ANTIVIRAL agents, MACHINE learning, DISEASE relapse, NUCLEOSIDE reverse transcriptase inhibitors, BIOMARKERS, PATIENT aftercare |
| مستخلص: |
Chronic hepatitis B, a major cause of liver disease and cancer, affects >250 million people worldwide. Currently there is no cure, only suppressive therapies. Efforts to develop finite curative hepatitis B virus (HBV) therapies are underway, consisting of combinations of multiple novel agents with or without nucleos(t)ide reverse-transcriptase inhibitors. The HBV Forum convened a webinar in July 2021, along with subsequent working group discussions to address how and when to stop finite therapy for demonstration of sustained off-treatment efficacy and safety responses. Participants included leading experts in academia, clinical practice, pharmaceutical companies, patient representatives, and regulatory agencies. This Viewpoints article outlines areas of consensus within our multistakeholder group for stopping finite therapies in chronic hepatitis B investigational studies, including trial design, patient selection, outcomes, biomarkers, predefined stopping criteria, predefined retreatment criteria, duration of investigational therapies, and follow-up after stopping therapy. Future research of unmet needs are discussed. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
